Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724093 | SCV000228503 | uncertain significance | not provided | 2014-09-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000467630 | SCV000542873 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2016-11-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724093 | SCV000618220 | likely benign | not provided | 2019-09-16 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26272908) |
Ambry Genetics | RCV002326967 | SCV002627755 | uncertain significance | Cardiovascular phenotype | 2019-03-14 | criteria provided, single submitter | clinical testing | The p.R14414W variant (also known as c.43240C>T), located in coding exon 153 of the TTN gene, results from a C to T substitution at nucleotide position 43240. The arginine at codon 14414 is replaced by tryptophan, an amino acid with dissimilar properties. This variant (reported as p.R21838W, c.65512C>T) co-occurred with additional variants in cardiac-related genes in a sudden unexplained death case (Santori M et al. Arch. Dis. Child., 2015 Oct;100:952-6). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |